The Lawyer’s newest product is the most comprehensive overview of the Asia-Pacific legal market yet produced. With rankings of the top 100 local law firms by lawyer headcount as well as analysis of the leading 50 international players in the region, it is essential reading for anyone interested in the strategic future of the world’s fastest growing legal market
Kurt Geiger general counsel Suzanne Smith is to leave the company to return to the pharmaceuticals sector, joining global biotechnology corporation Genzyme.
Smith joined Kurt Geiger a year ago from pharma company Phoqus Pharmaceuticals, where she was general counsel. She joined Phoqus in February 2005 and was appointed company secretary in January 2007.
Smith will join US company Genzyme later this year as legal director for the UK and Ireland, a role that has been created for her. The biotechnology company headhunted her for the position.
Genzyme has more than 11,000 employees in locations across the globe, including four offices in the UK and one in Ireland.
It develops products and services that focus on rare inherited disorders, including kidney disease, orthopaedics, cancer, transplant and immune disease, as well as diagnostic testing.
Kurt Geiger is currently looking for a replacement.